237 related articles for article (PubMed ID: 21555577)
21. Initial Viral Inoculum Determines Kinapse-and Synapse-Like T Cell Motility in Reactive Lymph Nodes.
Sivapatham S; Ficht X; Barreto de Albuquerque J; Page N; Merkler D; Stein JV
Front Immunol; 2019; 10():2086. PubMed ID: 31552034
[TBL] [Abstract][Full Text] [Related]
22. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
[TBL] [Abstract][Full Text] [Related]
23. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model.
Liao H; Franck E; Fréret M; Adriouch S; Baba-Amer Y; Authier FJ; Boyer O; Gherardi RK
Arthritis Rheum; 2012 Oct; 64(10):3441-51. PubMed ID: 22674045
[TBL] [Abstract][Full Text] [Related]
24. Predicting lymph node output efficiency using systems biology.
Gong C; Mattila JT; Miller M; Flynn JL; Linderman JJ; Kirschner D
J Theor Biol; 2013 Oct; 335():169-84. PubMed ID: 23816876
[TBL] [Abstract][Full Text] [Related]
25. Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy.
Mittal P; St Rose MC; Wang X; Ryan JM; Wasser JS; Vella AT; Adler AJ
J Immunol; 2015 Dec; 195(12):5816-26. PubMed ID: 26561553
[TBL] [Abstract][Full Text] [Related]
26. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.
Serre K; Giraudo L; Siret C; Leserman L; Machy P
Eur J Immunol; 2006 Jun; 36(6):1386-97. PubMed ID: 16673447
[TBL] [Abstract][Full Text] [Related]
27. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression.
McLellan AD; Kapp M; Eggert A; Linden C; Bommhardt U; Bröcker EB; Kämmerer U; Kämpgen E
Blood; 2002 Mar; 99(6):2084-93. PubMed ID: 11877283
[TBL] [Abstract][Full Text] [Related]
28. CD4+ and CD8+ T cells exhibit differential requirements for CCR7-mediated antigen transport during influenza infection.
Heer AK; Harris NL; Kopf M; Marsland BJ
J Immunol; 2008 Nov; 181(10):6984-94. PubMed ID: 18981118
[TBL] [Abstract][Full Text] [Related]
29. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
30. Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor.
Baxevanis CN; Voutsas IF; Tsitsilonis OE; Gritzapis AD; Sotiriadou R; Papamichail M
J Immunol; 2000 Apr; 164(7):3902-12. PubMed ID: 10725753
[TBL] [Abstract][Full Text] [Related]
31. CD4+ T cells can protect APC from CTL-mediated elimination.
Mueller SN; Jones CM; Stock AT; Suter M; Heath WR; Carbone FR
J Immunol; 2006 Jun; 176(12):7379-84. PubMed ID: 16751382
[TBL] [Abstract][Full Text] [Related]
32. CD8 T cell priming by B lymphocytes is CD4 help dependent.
Castiglioni P; Gerloni M; Cortez-Gonzalez X; Zanetti M
Eur J Immunol; 2005 May; 35(5):1360-70. PubMed ID: 15816014
[TBL] [Abstract][Full Text] [Related]
33. A role for dendritic cells in the priming of antigen-specific CD4+ and CD8+ T lymphocytes by immune-stimulating complexes in vivo.
Beacock-Sharp H; Donachie AM; Robson NC; Mowat AM
Int Immunol; 2003 Jun; 15(6):711-20. PubMed ID: 12750355
[TBL] [Abstract][Full Text] [Related]
34. Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses.
Hugues S; Scholer A; Boissonnas A; Nussbaum A; Combadière C; Amigorena S; Fetler L
Nat Immunol; 2007 Sep; 8(9):921-30. PubMed ID: 17660821
[TBL] [Abstract][Full Text] [Related]
35. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
[TBL] [Abstract][Full Text] [Related]
36. CD4
Borst J; Ahrends T; Bąbała N; Melief CJM; Kastenmüller W
Nat Rev Immunol; 2018 Oct; 18(10):635-647. PubMed ID: 30057419
[TBL] [Abstract][Full Text] [Related]
37. Type 1 Conventional CD103
Ng SL; Teo YJ; Setiagani YA; Karjalainen K; Ruedl C
Front Immunol; 2018; 9():3043. PubMed ID: 30622538
[TBL] [Abstract][Full Text] [Related]
38. Quantification of lymph node transit times reveals differences in antigen surveillance strategies of naive CD4+ and CD8+ T cells.
Mandl JN; Liou R; Klauschen F; Vrisekoop N; Monteiro JP; Yates AJ; Huang AY; Germain RN
Proc Natl Acad Sci U S A; 2012 Oct; 109(44):18036-41. PubMed ID: 23071319
[TBL] [Abstract][Full Text] [Related]
39. Murine CD4+ T cell responses are inhibited by cytotoxic T cell-mediated killing of dendritic cells and are restored by antigen transfer.
Ma JZ; Lim SN; Qin JS; Yang J; Enomoto N; Ruedl C; Ronchese F
PLoS One; 2012; 7(5):e37481. PubMed ID: 22649530
[TBL] [Abstract][Full Text] [Related]
40. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity.
Smith CM; Wilson NS; Waithman J; Villadangos JA; Carbone FR; Heath WR; Belz GT
Nat Immunol; 2004 Nov; 5(11):1143-8. PubMed ID: 15475958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]